ロード中...
Evaluation of bleeding in patients receiving direct oral anticoagulants
Direct oral anticoagulants (DOACs) are recognized by evidence-based treatment guidelines as the first-line option for the treatment of venous thromboembolism and prevention of stroke and systemic embolism in nonvalvular atrial fibrillation. As use of these anticoagulants has become favored over the...
保存先:
| 出版年: | Vasc Health Risk Manag |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5574591/ https://ncbi.nlm.nih.gov/pubmed/28860793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S121661 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|